Innoviva INVA Peer Comparison

NASDAQ INVA
$21.24 -0.11 (-0.52%)
As of: Sep 4, 2026 · 2:20 PM EDT
Peer Comparison

300 Comparable Companies

Industry Pharmaceuticals

Innoviva, Inc. (INVA) is the 136th largest of 300 Pharmaceuticals companies by market capitalisation, at 1.56 Bn, behind Ascentage Pharma Group International at 1.57 Bn. It trades on a P/E of 7.94, 60% below the peer median of 19.61. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 JNJ Johnson & Johnson primary H-01 Pharmaceuticals and Biotechnology HG-01 663.00 Bn 31.52 6.77 642.24 Bn
2 ABBV AbbVie Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 452.66 Bn 71.67 7.03 446.09 Bn
3 MRK Merck & Co., Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 371.61 Bn 117.26 5.58 364.47 Bn
4 NVS Novartis Ag primary H-01 Pharmaceuticals and Biotechnology HG-01 309.79 Bn 13.77 4.51 302.10 Bn
5 PFE Pfizer Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 162.45 Bn 37.19 2.55 150.75 Bn
6 SNY Sanofi primary H-01 Pharmaceuticals and Biotechnology HG-01 53.81 Bn 11.54 1.00 46.43 Bn
7 RVMD Revolution Medicines, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 44.07 Bn -24.92 — 44.07 Bn
8 ONC BeOne Medicines Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 39.99 Bn 60.99 6.52 34.89 Bn
9 INCY Incyte Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 25.64 Bn 15.90 4.41 21.11 Bn
10 UTHR UNITED THERAPEUTICS Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 20.84 Bn 15.90 6.61 18.18 Bn
11 NBIX Neurocrine Biosciences Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.71 Bn 22.27 4.66 15.32 Bn
12 JAZZ Jazz Pharmaceuticals plc primary H-01 Pharmaceuticals and Biotechnology HG-01 15.63 Bn 16.61 3.40 14.01 Bn
13 EXEL Exelixis, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 14.82 Bn 17.22 6.08 13.98 Bn
14 CORT Corcept Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 11.79 Bn 217.60 14.20 11.49 Bn
15 KYMR Kymera Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 11.55 Bn -38.54 109.96 10.85 Bn
16 AXSM Axsome Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.71 Bn -69.64 13.79 10.39 Bn
17 GPCR Structure Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 10.28 Bn -54.65 — 10.28 Bn
18 NUVL Nuvalent, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 9.75 Bn -27.07 — 9.75 Bn
19 CYTK Cytokinetics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 9.59 Bn -13.07 141.69 8.42 Bn
20 CRNX Crinetics Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 8.99 Bn -17.90 213.22 8.99 Bn
21 ALKS Alkermes plc. primary H-01 Pharmaceuticals and Biotechnology HG-01 7.76 Bn 117.36 4.65 7.11 Bn
22 BLTE Belite Bio, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -81.06 — 6.25 Bn
23 TVTX Travere Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 6.14 Bn -141.15 10.37 6.14 Bn
24 LQDA Liquidia Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 6.11 Bn 44.09 13.55 5.83 Bn
25 AMRN Amarin Corp Plc\Uk primary H-01 Pharmaceuticals and Biotechnology HG-01 5.67 Bn -209.11 30.46 5.36 Bn
26 ACAD Acadia Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 4.82 Bn 12.66 4.23 3.86 Bn
27 EWTX Edgewise Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.60 Bn -23.34 — 4.60 Bn
28 DFTX Definium Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.26 Bn -12.03 — 4.26 Bn
29 INDV Indivior Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 4.18 Bn 11.76 3.13 3.95 Bn
30 MANE Veradermics, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 3.99 Bn -46.29 — 3.99 Bn
31 ELVN Enliven Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.94 Bn -46.86 — 3.94 Bn
32 CPRX CATALYST PHARMACEUTICALS, INC. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.85 Bn 17.94 6.45 3.09 Bn
33 TARS Tarsus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.76 Bn -80.18 6.21 3.31 Bn
34 OGN Organon & Co. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.62 Bn 17.31 0.59 2.49 Bn
35 NAMS NewAmsterdam Pharma Co N.V. primary H-01 Pharmaceuticals and Biotechnology HG-01 3.13 Bn -12.06 439.49 3.13 Bn
36 TRVI Trevi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.69 Bn -63.86 — 2.69 Bn
37 TAK Takeda Pharmaceutical Co Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 2.64 Bn 4.61 0.06 -3.15 Bn
38 SUPN Supernus Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.55 Bn -29.99 3.24 2.18 Bn
39 HRMY Harmony Biosciences Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn 13.70 2.55 1.64 Bn
40 NUVB Nuvation Bio Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.39 Bn -22.09 14.06 2.39 Bn
41 MLYS Mineralys Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -6.77 — 2.37 Bn
42 PVLA Palvella Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.24 Bn -42.20 — 1.92 Bn
43 AUPH Aurinia Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 6.69 6.75 1.66 Bn
44 ETON Eton Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 169.72 16.16 1.59 Bn
45 INVA Innoviva, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.56 Bn 7.94 3.03 0.98 Bn
46 LBRX Lb Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -24.55 — 1.49 Bn
47 XERS Xeris Biopharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -85.73 4.39 1.35 Bn
48 HROW Harrow, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -42.63 5.17 1.34 Bn
49 OPK Opko Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.24 Bn -32.79 2.11 0.94 Bn
50 KURA Kura Oncology, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -4.91 15.13 1.17 Bn
51 OLMA Olema Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.13 Bn -5.54 — 1.13 Bn
52 PCRX Pacira BioSciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 1.04 Bn 71.08 1.39 0.79 Bn
53 LXRX Lexicon Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -15.55 23.59 0.79 Bn
54 SGP SpyGlass Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -48.80 — 0.97 Bn
55 DSGN Design Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -11.79 — 0.75 Bn
56 IVA Inventiva S.A. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.89 Bn 9.70 179.22 0.89 Bn
57 VSTM Verastem, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -6.99 9.21 0.67 Bn
58 COLL Collegium Pharmaceutical, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 16.25 0.96 0.63 Bn
59 PHAT Phathom Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.91 3.24 0.59 Bn
60 ZVRA Zevra Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.73 Bn 12.60 5.39 0.51 Bn
61 GYRE Gyre Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -36.84 5.70 0.62 Bn
62 AQST Aquestive Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -8.65 12.51 0.68 Bn
63 CRMD CorMedix Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 5.30 1.78 0.41 Bn
64 MPLT MapLight Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -3.13 — 0.63 Bn
65 EOLS Evolus, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -17.65 1.91 0.56 Bn
66 NVCT Nuvectis Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -18.97 — 0.57 Bn
67 SPRY ARS Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -2.52 4.77 0.41 Bn
68 OVID Ovid Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -16.00 348.63 0.43 Bn
69 XFOR X4 Pharmaceuticals, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -5.69 32.37 0.32 Bn
70 PALI Palisade Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -12.40 875.12 0.31 Bn
71 IKT Inhibikase Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -6.63 — 0.27 Bn
72 VTVT vTv Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -87.07 11.24 0.41 Bn
73 ACHV Achieve Life Sciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.37 Bn — — 0.37 Bn
74 VNDA Vanda Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -1.18 1.51 0.16 Bn
75 EBS Emergent BioSolutions Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.82 0.42 0.18 Bn
76 SION Sionna Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.29 — 0.32 Bn
77 IMRX Immuneering Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -5.39 — 0.32 Bn
78 TTRX Turn Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -39.36 — 0.30 Bn
79 FULC Fulcrum Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -3.30 — 0.29 Bn
80 ZNTL Zentalis Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.05 — 0.29 Bn
81 AKBA Akebia Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.01 1.22 0.11 Bn
82 CELG-RI Bristol Myers Squibb Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.03 0.01 -10.82 Bn
83 SIGA Siga Technologies Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.24 Bn — — 0.08 Bn
84 TNXP Tonix Pharmaceuticals Holding Corp. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.37 7.52 0.22 Bn
85 DERM Journey Medical Corp primary H-01 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -59.75 3.20 0.19 Bn
86 NERV Minerva Neurosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -32.50 — 0.21 Bn
87 ACOG Alpha Cognition Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -7.49 15.36 0.16 Bn
88 SLGL Sol-Gel Technologies Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -18.26 106.68 0.14 Bn
89 MCUJF Medicure Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -35.91 8.18 0.19 Bn
90 CRDL Cardiol Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -7.23 — 0.17 Bn
91 LONA LeonaBio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -1.53 — 0.14 Bn
92 LENZ LENZ Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.40 8.46 0.18 Bn
93 MENS Jyong Biotech Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -44.35 — 0.17 Bn
94 BMEA Biomea Fusion, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -2.54 — 0.14 Bn
95 VANI Vivani Medical, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.73 — 0.11 Bn
96 NTHI Neonc Technologies Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.83 — 0.13 Bn
97 AARD Aardvark Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.70 — 0.04 Bn
98 VRCA Verrica Pharmaceuticals Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.63 3.76 0.10 Bn
99 CPIX Cumberland Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.44 3.25 0.10 Bn
100 RGC Regencell Bioscience Holdings Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
101 CGTX Cognition Therapeutics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.51 — 0.09 Bn
102 PTHS Pelthos Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -0.78 1.61 0.06 Bn
103 TENX Tenax Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.32 — 0.09 Bn
104 MNOV Medicinova Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -6.94 91.29 0.08 Bn
105 PLRX Pliant Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -0.76 — 0.07 Bn
106 PMVP PMV Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.13 — -0.01 Bn
107 CING Cingulate Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.11 — 0.07 Bn
108 BOLD Boundless Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -1.00 — 0.06 Bn
109 VERU Veru Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 124.51 — 0.04 Bn
110 GOSS Gossamer Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.33 1.05 0.00 Bn
111 KPTI Karyopharm Therapeutics Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.26 0.35 0.05 Bn
112 ANVS Annovis Bio, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.06 — 0.05 Bn
113 CLNN Clene Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.40 222.77 0.05 Bn
114 APRE Aprea Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -3.44 — 0.04 Bn
115 IXHL Incannex Healthcare Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.83 — 0.04 Bn
116 SCLX Scilex Holding Co primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.08 1.20 -0.07 Bn
117 GRCE Grace Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.81 — 0.04 Bn
118 CPHI China Pharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -7.57 8.65 0.03 Bn
119 UG United Guardian Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 14.61 2.95 0.02 Bn
120 ACTU Actuate Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.59 — 0.03 Bn
121 NSRX Nasus Pharma Ltd primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -5.64 — 0.03 Bn
122 YARW Yarrow Bioscience, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.27 53.05 0.00 Bn
123 CRVO CervoMed Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.87 79.47 0.03 Bn
124 BYSI BeyondSpring Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.07 — 0.03 Bn
125 TXMD TherapeuticsMD, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -137.01 7.75 0.02 Bn
126 AYTU Aytu Biopharma, Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.77 0.42 0.00 Bn
127 ALLR Allarity Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.89 916.46 0.02 Bn
128 ATOS Atossa Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.75 — 0.02 Bn
129 BFRI Biofrontera Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.29 0.45 0.02 Bn
130 MIRA Mira Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.55 — 0.01 Bn
131 TVRD Tvardi Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.67 — 0.02 Bn
132 KPRX Kiora Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.47 — 0.02 Bn
133 INTI Inhibitor Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -4.72 — 0.02 Bn
134 CTXR Citius Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.33 2.16 0.02 Bn
135 ANEB Anebulo Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.37 — 0.01 Bn
136 RVPH Reviva Pharmaceuticals Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.82 — 0.01 Bn
137 CALC CalciMedica, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 -8.60 -0.01 Bn
138 CURX Curanex Pharmaceuticals Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.95 — 0.00 Bn
139 ADXN Addex Therapeutics Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn 0.05 — 0.01 Bn
140 ACXP Acurx Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.80 — 0.01 Bn
141 TRAW Traws Pharma, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.35 — 0.00 Bn
142 PCSA Processa Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -0.42 — 0.01 Bn
143 PULM Pulmatrix, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.01 Bn -1.27 — 0.01 Bn
144 TCRT Alaunos Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.99 1,337.11 0.00 Bn
145 CVKD Cadrenal Therapeutics, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.31 — 0.00 Bn
146 BICX BioCorRx Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.64 6.70 0.00 Bn
147 CASIF CASI Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.02 0.12 0.00 Bn
148 SKVI Skinvisible, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -2.25 116.18 0.00 Bn
149 OGEN Oragenics Inc primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.22 — 0.00 Bn
150 UPC Universe Pharmaceuticals INC primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -1,490.23 Bn
151 CANF Can-Fite BioPharma Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.21 5.02 -0.01 Bn
152 MTNB Matinas BioPharma Holdings, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.16 — 0.00 Bn
153 ENSC Ensysce Biosciences, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — 0.00 Bn
154 SPRC SciSparc Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.05 0.77 0.00 Bn
155 NCEL NewcelX Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.06 — 0.00 Bn
156 JAGX Jaguar Health, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 0.02 -0.01 Bn
157 GLMD Galmed Pharmaceuticals Ltd. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn — — -0.01 Bn
158 CDT CDT Equity Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -0.01 — 0.00 Bn
159 GCAN Trafalgar International, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn -1.77 — 0.00 Bn
160 SXTC China SXT Pharmaceuticals, Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 0.03 -0.03 Bn
161 CMND Clearmind Medicine Inc. primary H-01 Pharmaceuticals and Biotechnology HG-01 0.00 Bn 0.00 — -0.01 Bn
162 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 187.36 Bn -64.72 6.15 184.18 Bn
163 QCOM Qualcomm Inc/De secondary T-01 Semiconductors TG-01 178.40 Bn 19.27 4.05 170.10 Bn
164 UBS UBS Group AG secondary F-02 Banking FG-01 174.77 Bn 20.08 8.01 -234.10 Bn
165 BLK BlackRock, Inc. secondary F-09 Asset and Wealth Management FG-03 174.32 Bn 26.48 6.39 160.45 Bn
166 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 138.87 Bn 31.52 11.03 131.01 Bn
167 BNY Bank of New York Mellon Corp secondary F-21 Capital Markets FG-05 113.73 Bn 18.88 5.33 52.50 Bn
168 BX Blackstone Inc. secondary F-11 Asset and Wealth Management FG-03 109.46 Bn 16.04 6.79 106.95 Bn
169 KKR KKR & Co. Inc. secondary F-11 Asset and Wealth Management FG-03 96.68 Bn 32.33 4.54 -180.39 Bn
170 BN BROOKFIELD Corp /ON/ secondary F-11 Asset and Wealth Management FG-03 90.59 Bn 63.44 1.18 59.80 Bn
171 DB Deutsche Bank Aktiengesellschaft secondary F-02 Banking FG-01 80.95 Bn 9.63 2.17 -277.63 Bn
172 BAM Brookfield Asset Management Ltd. secondary F-11 Asset and Wealth Management FG-03 80.85 Bn 28.83 14.09 79.35 Bn
173 APO Apollo Global Management, Inc. secondary F-11 Asset and Wealth Management FG-03 79.16 Bn 44.52 2.20 53.78 Bn
174 WPM Wheaton Precious Metals Corp. secondary F-11 Asset and Wealth Management FG-03 70.41 Bn 31.42 21.46 70.31 Bn
175 FNV FRANCO NEVADA Corp secondary F-11 Asset and Wealth Management FG-03 51.36 Bn 33.19 22.17 49.82 Bn
176 IX Orix Corp secondary F-06 Lending and Credit FG-02 44.65 Bn 11.13 1.99 30.83 Bn
177 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.49 Bn 61.05 2.45 38.83 Bn
178 ALC Alcon Inc secondary H-06 Medical Devices and Diagnostics HG-02 34.90 Bn 29.30 3.24 33.44 Bn
179 ARES Ares Management Corp secondary F-11 Asset and Wealth Management FG-03 31.69 Bn 59.23 5.29 31.69 Bn
180 GEHC GE HealthCare Technologies Inc. secondary H-08 Medical Devices and Diagnostics HG-02 31.13 Bn 15.18 1.46 29.02 Bn
181 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.41 Bn -31.31 24.09 26.25 Bn
182 PFG Principal Financial Group Inc secondary F-09 Asset and Wealth Management FG-03 25.29 Bn 16.03 1.61 -27.67 Bn
183 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 25.22 Bn -16.99 2,309.22 25.22 Bn
184 MKL Markel Group Inc. secondary F-13 Insurance FG-04 23.02 Bn 10.04 1.48 6.13 Bn
185 LEN Lennar Corp /New/ secondary D-08 Homebuilding DG-03 20.18 Bn 10.10 0.62 18.00 Bn
186 FTAI FTAI Aviation Ltd. secondary I-01 Aerospace and Defense IG-01 20.05 Bn 41.97 6.44 19.71 Bn
187 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.74 Bn -48.05 1.34 18.85 Bn
188 BEN Franklin Resources Inc secondary F-09 Asset and Wealth Management FG-03 18.01 Bn 15.84 1.93 14.30 Bn
189 CG Carlyle Group Inc. secondary F-11 Asset and Wealth Management FG-03 16.87 Bn 31.19 4.67 15.61 Bn
190 IVZ Invesco Ltd. secondary F-09 Asset and Wealth Management FG-03 15.00 Bn -48.50 2.17 14.08 Bn
191 BWXT BWX Technologies, Inc. secondary I-39 Clean Energy Equipment IG-10 14.46 Bn 40.61 4.12 13.86 Bn
192 RNR Renaissancere Holdings Ltd secondary F-15 Insurance FG-04 13.72 Bn 5.28 1.23 -12.76 Bn
193 AFG American Financial Group Inc secondary F-13 Insurance FG-04 11.90 Bn 13.63 1.44 -5.95 Bn
194 JEF Jefferies Financial Group Inc. secondary F-17 Capital Markets FG-05 11.73 Bn 14.72 0.99 -3.72 Bn
195 GKOS GLAUKOS Corp secondary H-06 Medical Devices and Diagnostics HG-02 10.49 Bn -66.62 17.12 10.38 Bn
196 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.24 Bn -26.84 — 9.48 Bn
197 AMG Affiliated Managers Group, Inc. secondary F-09 Asset and Wealth Management FG-03 9.75 Bn 9.27 4.30 9.34 Bn
198 VOYA Voya Financial, Inc. secondary F-09 Asset and Wealth Management FG-03 9.51 Bn 16.77 1.16 7.16 Bn
199 ARE Alexandria Real Estate Equities, Inc. secondary R-02 Property REITs RG-01 9.00 Bn -8.73 3.17 7.90 Bn
200 TPG TPG Inc. secondary F-11 Asset and Wealth Management FG-03 8.75 Bn 12.90 1.69 7.80 Bn
201 OWL Blue Owl Capital Inc. secondary F-11 Asset and Wealth Management FG-03 8.10 Bn 23.94 2.71 7.93 Bn
202 VCTR Victory Capital Holdings, Inc. secondary F-09 Asset and Wealth Management FG-03 7.05 Bn 19.95 4.52 6.98 Bn
203 TFPM Triple Flag Precious Metals Corp. secondary F-11 Asset and Wealth Management FG-03 6.91 Bn 14.39 14.14 6.90 Bn
204 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.46 Bn -721.19 4,640.10 6.46 Bn
205 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.46 Bn -39.61 1.21 6.08 Bn
206 BXSL Blackstone Secured Lending Fund secondary F-07 Lending and Credit FG-02 5.78 Bn 17.51 4.24 5.52 Bn
207 RITM Rithm Capital Corp. secondary F-08 Lending and Credit FG-02 5.63 Bn 16.82 1.11 5.63 Bn
208 AMRX Amneal Pharmaceuticals, Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 5.56 Bn 25.81 1.78 5.43 Bn
209 MAIN Main Street Capital CORP secondary F-07 Lending and Credit FG-02 5.40 Bn 15.74 9.38 5.34 Bn
210 PFH Prudential Financial Inc secondary F-12 Insurance FG-04 5.28 Bn 1.35 0.08 -26.64 Bn
211 PIPR Piper Sandler Companies secondary F-17 Capital Markets FG-05 5.20 Bn 14.30 2.46 4.90 Bn
212 WTM White Mountains Insurance Group Ltd secondary F-13 Insurance FG-04 5.10 Bn 4.32 1.33 -6.32 Bn
213 CIGI Colliers International Group Inc. secondary R-16 Real Estate Services RG-04 5.05 Bn 30.39 0.85 4.78 Bn
214 GLXY Galaxy Digital Inc. secondary F-22 Capital Markets FG-05 5.04 Bn -18.11 0.09 3.49 Bn
215 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.04 Bn -17.54 — 5.04 Bn
216 PECO Phillips Edison & Company, Inc. secondary R-03 Property REITs RG-01 4.94 Bn — 6.58 4.94 Bn
217 HASI HA Sustainable Infrastructure Capital, Inc. secondary F-11 Asset and Wealth Management FG-03 4.89 Bn 54.95 10.56 4.64 Bn
218 PJT PJT Partners Inc. secondary F-17 Capital Markets FG-05 4.88 Bn 12.99 2.58 4.26 Bn
219 HCXY Hercules Capital, Inc. secondary F-07 Lending and Credit FG-02 4.67 Bn 20.16 8.25 4.62 Bn
220 IEP Icahn Enterprises L.P. secondary E-06 Refining and Marketing EG-03 4.59 Bn -10.37 0.42 2.62 Bn
221 LAZ Lazard, Inc. secondary F-17 Capital Markets FG-05 4.54 Bn 30.01 1.37 3.44 Bn
222 IBOC International Bancshares Corp secondary F-01 Banking FG-01 4.46 Bn 10.82 58.23 4.46 Bn
223 HLNE Hamilton Lane INC secondary F-11 Asset and Wealth Management FG-03 4.29 Bn 9.84 4.99 3.95 Bn
224 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.18 Bn -8.17 1,159.80 4.18 Bn
225 CNS Cohen & Steers, Inc. secondary F-09 Asset and Wealth Management FG-03 4.12 Bn 15.52 4.86 4.06 Bn
226 STEP StepStone Group Inc. secondary F-11 Asset and Wealth Management FG-03 4.04 Bn — — 3.14 Bn
227 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.73 Bn -8.11 31.87 3.03 Bn
228 WT WisdomTree, Inc. secondary F-09 Asset and Wealth Management FG-03 3.71 Bn 46.29 6.09 3.42 Bn
229 AB Alliancebernstein Holding L.P. secondary F-09 Asset and Wealth Management FG-03 3.49 Bn — — 3.49 Bn
230 BRBI BRBI BR Partners S.A. secondary F-17 Capital Markets FG-05 3.44 Bn 134.48 30.84 3.32 Bn
231 GBDC GOLUB CAPITAL BDC, Inc. secondary F-07 Lending and Credit FG-02 3.38 Bn -38.82 4.23 3.34 Bn
232 SII Sprott Inc. secondary F-09 Asset and Wealth Management FG-03 3.33 Bn 31.78 8.34 3.14 Bn
233 AGO Assured Guaranty Ltd secondary F-13 Insurance FG-04 3.33 Bn 8.70 3.54 -0.46 Bn
234 AAMI Acadian Asset Management Inc. secondary F-09 Asset and Wealth Management FG-03 3.32 Bn 28.28 4.97 3.26 Bn
235 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn -11.29 593.06 2.53 Bn
236 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -15.60 6.53 2.23 Bn
237 DBRG DigitalBridge Group, Inc. secondary F-11 Asset and Wealth Management FG-03 2.89 Bn 10.25 3.63 2.38 Bn
238 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.87 Bn -8.41 78.10 2.43 Bn
239 APAM Artisan Partners Asset Management Inc. secondary F-09 Asset and Wealth Management FG-03 2.75 Bn 7.38 2.20 2.42 Bn
240 AKR Acadia Realty Trust secondary R-03 Property REITs RG-01 2.72 Bn 51.96 6.74 2.72 Bn
241 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.62 Bn -80.63 — 2.62 Bn
242 CURLF Curaleaf Holdings, Inc. secondary S-09 Tobacco and Cannabis SG-04 2.55 Bn -21.56 1.95 2.46 Bn
243 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.54 Bn -6.61 4.75 2.19 Bn
244 BHC Bausch Health Companies Inc. secondary H-04 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -2.25 0.23 0.62 Bn
245 OAK-PA Brookfield Oaktree Holdings, LLC secondary F-11 Asset and Wealth Management FG-03 2.40 Bn 7.99 3.89 2.40 Bn
246 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.37 Bn -4.04 — 2.10 Bn
247 FMS Fresenius Medical Care AG secondary H-14 Healthcare Providers HG-04 2.20 Bn 1.85 0.08 0.37 Bn
248 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -4.99 2,075.13 2.08 Bn
249 PGY Pagaya Technologies Ltd. secondary T-56 Fintech TG-09 1.90 Bn 16.28 1.37 1.65 Bn
250 PAX Patria Investments Ltd secondary F-11 Asset and Wealth Management FG-03 1.79 Bn -132.85 57.63 1.61 Bn
251 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -3.44 2.22 1.30 Bn
252 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -9.11 20.12 1.29 Bn
253 KW Kennedy-Wilson Holdings, Inc. secondary R-19 Property Developers RG-05 1.52 Bn 96.40 3.11 1.37 Bn
254 ANIP Ani Pharmaceuticals Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 1.51 Bn 13.96 1.54 1.15 Bn
255 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -9.04 — 1.48 Bn
256 WD Walker & Dunlop, Inc. secondary F-05 Lending and Credit FG-02 1.41 Bn 39.93 1.09 1.25 Bn
257 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 80.63 35.82 1.38 Bn
258 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn -28.10 — 1.13 Bn
259 PWP Perella Weinberg Partners secondary F-17 Capital Markets FG-05 1.24 Bn 44.26 1.79 1.12 Bn
260 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -72.81 — 0.96 Bn
261 PURR Hyperliquid Strategies Inc secondary F-11 Asset and Wealth Management FG-03 0.98 Bn 2.42 160.83 0.84 Bn
262 CIM Chimera Investment Corp secondary F-08 Lending and Credit FG-02 0.97 Bn -11.51 — 0.53 Bn
263 BUR Burford Capital Ltd secondary F-06 Lending and Credit FG-02 0.95 Bn -0.56 0.49 0.95 Bn
264 RPC Ridgepost Capital, Inc. secondary F-11 Asset and Wealth Management FG-03 0.92 Bn 27.98 2.95 0.89 Bn
265 ABX Abacus Global Management, Inc. secondary F-11 Asset and Wealth Management FG-03 0.91 Bn 32.29 3.41 0.89 Bn
266 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn -11.05 106.98 0.88 Bn
267 ANSC Agriculture & Natural Solutions Acquisition Corp secondary F-11 Asset and Wealth Management FG-03 0.85 Bn -71.21 55.39 0.85 Bn
268 GCMG GCM Grosvenor Inc. secondary F-11 Asset and Wealth Management FG-03 0.81 Bn 5.30 1.42 0.67 Bn
269 FPH Five Point Holdings, LLC secondary R-18 Property Developers RG-05 0.75 Bn 5.40 6.44 0.40 Bn
270 NMFC New Mountain Finance Corp secondary F-07 Lending and Credit FG-02 0.71 Bn 63.40 2.46 0.65 Bn
271 CNNE Cannae Holdings, Inc. secondary F-11 Asset and Wealth Management FG-03 0.69 Bn -1.58 1.16 0.62 Bn
272 FERA Fifth Era Acquisition Corp I secondary F-11 Asset and Wealth Management FG-03 0.66 Bn 167.71 — 0.66 Bn
273 DMII Drugs Made In America Acquisition II Corp. secondary F-11 Asset and Wealth Management FG-03 0.65 Bn 187.36 — 0.65 Bn
274 ELE Elemental Royalty Corp secondary F-11 Asset and Wealth Management FG-03 0.64 Bn 0.14 8.76 0.57 Bn
275 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -364,186.03 — 0.35 Bn
276 LPBB Launch Two Acquisition Corp. secondary F-11 Asset and Wealth Management FG-03 0.62 Bn 90.68 — 0.62 Bn
277 LPAA Launch One Acquisition Corp. secondary F-11 Asset and Wealth Management FG-03 0.62 Bn 101.75 — 0.62 Bn
278 VINP Vinci Compass Investments Ltd. secondary F-11 Asset and Wealth Management FG-03 0.61 Bn 10.25 3.07 0.61 Bn
279 ALF Centurion Acquisition Corp. secondary F-11 Asset and Wealth Management FG-03 0.59 Bn 80.19 — 0.59 Bn
280 HCAC Hall Chadwick Acquisition Corp secondary F-11 Asset and Wealth Management FG-03 0.59 Bn -882.87 — 0.59 Bn
281 NOAH Noah Holdings Ltd secondary F-09 Asset and Wealth Management FG-03 0.59 Bn 6.95 1.57 -0.15 Bn
282 DCTH Delcath Systems, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.59 Bn 1,193.01 6.18 0.49 Bn
283 ABTC American Bitcoin Corp. secondary T-59 Fintech TG-09 0.57 Bn -2.28 2.09 0.54 Bn
284 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -8.00 24.04 0.26 Bn
285 GLRE Greenlight Capital Re, Ltd. secondary F-15 Insurance FG-04 0.51 Bn 9.98 0.70 -0.19 Bn
286 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -10.27 78.36 0.26 Bn
287 PLMKU Plum Acquisition Corp, IV secondary F-11 Asset and Wealth Management FG-03 0.46 Bn 120.26 — 0.46 Bn
288 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.74 44.84 0.25 Bn
289 IRD Opus Genetics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.53 44.69 0.35 Bn
290 ACTG Acacia Research Corp secondary F-11 Asset and Wealth Management FG-03 0.44 Bn -29.14 1.57 0.11 Bn
291 KFII K&F Growth Acquisition Corp. Ii secondary F-11 Asset and Wealth Management FG-03 0.43 Bn 37.72 — 0.43 Bn
292 CANE Teucrium Commodity Trust secondary F-09 Asset and Wealth Management FG-03 0.43 Bn -7.89 4.64 -0.11 Bn
293 ALTI AlTi Global, Inc. secondary F-09 Asset and Wealth Management FG-03 0.42 Bn -2.93 1.53 0.39 Bn
294 HAVA Harvard Ave Acquisition Corp secondary F-11 Asset and Wealth Management FG-03 0.42 Bn 198.26 — 0.42 Bn
295 CCIX Churchill Capital Corp IX/Cayman secondary F-11 Asset and Wealth Management FG-03 0.40 Bn 54.37 — 0.40 Bn
296 ALDF Aldel Financial II Inc. secondary F-11 Asset and Wealth Management FG-03 0.40 Bn 46.09 — 0.40 Bn
297 VLOS Velos Acquisition I Corp. secondary F-11 Asset and Wealth Management FG-03 0.39 Bn 103.55 — 0.39 Bn
298 SDHI Siddhi Acquisition Corp (Cayman Islands) secondary F-11 Asset and Wealth Management FG-03 0.37 Bn 46.13 — 0.37 Bn
299 BDCI BTC Development Corp. secondary F-11 Asset and Wealth Management FG-03 0.35 Bn 133.55 — 0.35 Bn
300 BEAGU Bold Eagle Acquisition Corp. secondary F-11 Asset and Wealth Management FG-03 0.35 Bn 53.69 — 0.35 Bn